Jubilant Pharmo

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE700A01033
  • NSEID: JUBLPHARMA
  • BSEID: 530019
INR
931.75
6.75 (0.73%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 1.78 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
15.80
15.80
15.80
15.90
15.92
15.92
Share Warrants & Outstandings
Total Reserve
7,077.00
6,239.10
5,418.10
5,383.40
5,302.64
4,725.57
Shareholder's Funds
7,092.80
6,254.90
5,433.90
5,399.30
5,318.56
4,741.49
Minority Interest
2.80
-16.30
-12.80
-7.50
-2.16
0.03
Long-Term Borrowings
2,971.70
2,150.30
3,167.10
3,110.40
2,464.24
2,563.97
Secured Loans
378.00
237.20
299.30
265.10
200.94
20.78
Unsecured Loans
2,593.70
1,913.10
2,867.80
2,845.30
2,263.30
2,543.19
Deferred Tax Assets / Liabilities
-6.40
-85.20
-21.90
78.70
141.69
92.59
Other Long Term Liabilities
2506.3
1911.6
760.4
483.7
219.99
222.48
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
159.50
119.10
100.10
92.20
95.67
94.01
Total Non-Current Liabilities
5,631.10
4,095.80
4,005.70
3,765.00
2,921.59
2,973.05
Current Liabilities
Trade Payables
1,234.10
1,004.80
856.30
821.30
567.74
520.48
Other Current Liabilities
962.70
794.80
719.30
573.10
473.65
418.54
Short Term Borrowings
247.80
286.60
247.00
299.70
463.37
20.00
Short Term Provisions
94.30
78.40
66.40
78.30
86.84
89.81
Total Current Liabilities
2,538.90
2,164.60
1,889.00
1,772.40
1,591.60
1,048.83
Total Liabilities
15,265.60
12,499.00
11,315.80
10,929.20
9,829.60
8,763.40
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
9,663.40
7,439.40
7,534.20
7,073.60
6,393.96
5,800.08
Less: Accumulated Depreciation
3,130.00
2,584.70
2,720.00
2,184.70
1,821.36
1,480.83
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
6,533.40
4,854.70
4,814.20
4,888.90
4,572.59
4,319.26
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
2,961.50
2,714.70
1,252.30
773.30
291.83
277.78
Intangible assets under development
1,078.90
915.30
850.80
788.20
797.74
619.21
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
61.40
43.50
42.20
256.40
238.60
240.96
Long Term Loans & Advances
73.10
60.10
191.90
161.50
117.64
62.84
Other Non Current Assets
15.80
12.30
11.30
4.10
3.98
1.35
Total Non-Current Assets
11,156.30
8,921.80
7,439.70
7,166.80
6,320.40
5,810.90
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,231.50
1,129.20
1,289.60
1,380.50
1,254.87
1,129.38
Sundry Debtors
1,069.60
891.50
915.90
961.20
927.99
819.90
Cash and Bank
1,267.60
1,088.80
956.80
1,014.30
984.24
671.32
Other Current Assets
366.50
331.30
523.40
227.20
168.81
194.56
Short Term Loans and Advances
174.10
136.40
190.40
179.20
173.28
137.34
Total Current Assets
4,109.30
3,577.20
3,876.10
3,762.40
3,509.19
2,952.50
Net Current Assets (Including Current Investments)
1,570.40
1,412.60
1,987.10
1,990.00
1,917.59
1,903.67
Total Current Assets Excluding Current Investments
4,109.30
3,577.20
3,876.10
3,762.40
3,509.19
2,952.50
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
15,265.60
12,499.00
11,315.80
10,929.20
9,829.60
8,763.40
Contingent Liabilities
419.40
368.40
456.20
402.30
402.77
404.11
Total Debt
3,219.50
2,436.90
3,414.10
3,410.10
2,927.62
2,583.97
Book Value per share (adjusted)
448.91
395.88
343.92
339.58
334.1
297.85
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 32.11% vs -28.62% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 31.11% vs 151.39% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 25.44% vs 24.77% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 41.15% vs 3.08% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 14.87% vs -7.71% in Mar 2025

Compare Balance Sheet Results of Jubilant Pharmo
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
15.80
39.31
-23.51
-59.81%
Share Warrants & Outstandings
Total Reserve
7,077.00
5,635.50
1,441.50
25.58%
Shareholder's Funds
7,092.80
5,674.81
1,417.99
24.99%
Minority Interest
2.80
-5.83
8.63
148.03%
Long-Term Borrowings
2,971.70
121.92
2,849.78
2,337.42%
Secured Loans
378.00
0.00
378.00
0.00%
Unsecured Loans
2,593.70
121.92
2,471.78
2,027.38%
Deferred Tax Assets / Liabilities
-6.40
-269.61
263.21
97.63%
Other Long Term Liabilities
2,506.30
224.94
2,281.36
1,014.21%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
159.50
152.91
6.59
4.31%
Total Non-Current Liabilities
5,631.10
230.16
5,400.94
2,346.60%
Current Liabilities
Trade Payables
1,234.10
835.08
399.02
47.78%
Other Current Liabilities
962.70
408.61
554.09
135.60%
Short Term Borrowings
247.80
1,238.93
-991.13
-80.00%
Short Term Provisions
94.30
111.21
-16.91
-15.21%
Total Current Liabilities
2,538.90
2,593.83
-54.93
-2.12%
Total Liabilities
15,265.60
8,492.97
6,772.63
79.74%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
9,663.40
4,896.98
4,766.42
97.33%
Less: Accumulated Depreciation
3,130.00
1,816.31
1,313.69
72.33%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
6,533.40
3,080.67
3,452.73
112.08%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
2,961.50
633.70
2,327.80
367.33%
Intangible assets under development
1,078.90
49.70
1,029.20
2,070.82%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
61.40
140.88
-79.48
-56.42%
Long Term Loans & Advances
73.10
15.43
57.67
373.75%
Other Non Current Assets
15.80
30.00
-14.20
-47.33%
Total Non-Current Assets
11,156.30
3,950.38
7,205.92
182.41%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
1,231.50
2,510.64
-1,279.14
-50.95%
Sundry Debtors
1,069.60
1,466.30
-396.70
-27.05%
Cash and Bank
1,267.60
202.70
1,064.90
525.36%
Other Current Assets
366.50
91.44
275.06
300.81%
Short Term Loans and Advances
174.10
271.51
-97.41
-35.88%
Total Current Assets
4,109.30
4,542.59
-433.29
-9.54%
Net Current Assets (Including Current Investments)
1,570.40
1,948.76
-378.36
-19.42%
Total Current Assets Excluding Current Investments
4,109.30
4,542.59
-433.29
-9.54%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
15,265.60
8,492.97
6,772.63
79.74%
Contingent Liabilities
419.40
160.39
259.01
161.49%
Total Debt
3,219.50
1,360.85
1,858.65
136.58%
Book Value per share (adjusted)
448.91
288.72
160.19
55.48%
Annual - Borrowings
Borrowings 3,219.50 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 32.11% vs -28.62% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 2,506.30 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 31.11% vs 151.39% in Mar 2025

Annual - Fixed Assets
Fixed Assets 9,494.90 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 25.44% vs 24.77% in Mar 2025

Annual - Investments
Investments 61.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 41.15% vs 3.08% in Mar 2025

Annual - Current Assets
Current Assets 4,109.30 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 14.87% vs -7.71% in Mar 2025